OncoMed Pharma Offers Data from New Clinical, Biomarker Trial from Tarextumab, Demcizumab
November 21, 2014 at 08:05 AM EST
OncoMed Pharmaceuticals, Inc. (Nasdaq: OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells ...